4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0001193125-26-072001
President and CEO sold 13,515 shares at $14.47 ($195,562)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| AHMED NADIM President and CEO | 2026-02-24 | Sale | −13,515 | $14.47 | $195,562 | 390,803 | D |
| Open-market sales · 13,515 sh · avg $14.47 · $195,562 | |||||||
Loading xslF345X05/ownership.xml…